HomeAbout UsProducts & TechnologyCliniciansPatients & FamiliesMedia CentreInvestor Centre
 
 
Investor Centre
 
Welcome'width='178
Corporate Profile
Investor Fact Sheet
Share Price Information
ASX Announcements
SEC Filings
News Releases
Annual Reports
Corporate Presentations
Events Calendar
Corporate Governance
Shareholder Services
Analyst Coverage
Investor FAQs
Email Alerts
Contact Investor Relations
 
 
 
 
 
 2010 ASX Announcements
 
 

Email Alerts Receive Email Alerts | RSS RSS Feeds
Keyword Search
 
2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
07/30/10HeartWare to Present at Wedbush Best Ideas ConferencePrinter Friendly Version
07/28/10Second Quarter Earnings Release CallPrinter Friendly Version
07/07/10Amended ASX Appendix 3BsPrinter Friendly Version
07/02/10Option Exercise - ASX Appendix 3BPrinter Friendly Version
07/02/10Option Grant - ASX Appendix 3BPrinter Friendly Version
06/25/10Announces Board SuccessionPrinter Friendly Version
06/18/10HeartWare to present at Wells FargoPrinter Friendly Version
06/18/10Exercise of Options - ASX Appendix 3BPrinter Friendly Version
06/15/10HeartWare To Commence Destination Therapy TrialPrinter Friendly Version
06/07/10Exercise and Cancellation of OptionsPrinter Friendly Version
05/07/10Change of Director`s Interest NoticesPrinter Friendly Version
05/05/10Annual General Meeting ResultsPrinter Friendly Version
05/05/10Grant of Incentive Equity - Appendix 3BPrinter Friendly Version
05/05/10Annual General Meeting MaterialsPrinter Friendly Version
05/05/10Appendix 3BPrinter Friendly Version
05/05/10First Quarter 2010 Financial StatementsPrinter Friendly Version
05/04/10First Quarter ResultsPrinter Friendly Version
05/03/10Appendix 3BPrinter Friendly Version
04/27/10Initiates voluntary repairs and recalls certain controllersPrinter Friendly Version
04/27/10First 100 Patient Commercial and Clinical DataPrinter Friendly Version
04/12/10Heartware to Report Financial Results First Quarter of 2010Printer Friendly Version
04/12/10Notice of Annual General MeetingPrinter Friendly Version
04/08/10FDA Approves Continued Access Protocol for BTTPrinter Friendly Version
03/26/10Amended ASX Appendix 3BPrinter Friendly Version
03/24/10Change of Director`s Interest NoticePrinter Friendly Version
03/24/10Appendix 3B - Exercise of Stock OptionsPrinter Friendly Version
03/05/10HeartWare to Present at Annual Roth Growth ConferencePrinter Friendly Version
03/03/10Grant and Cancellation of Equity - ASX Appendix 3BPrinter Friendly Version
03/03/10Change of Director's Interest NoticePrinter Friendly Version
03/03/10Appendix 3B - Vesting of Preformance RightsPrinter Friendly Version
02/24/10Annual Report for 2009 and ASX Appendix 4EPrinter Friendly Version
02/23/10Reports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2MPrinter Friendly Version
02/23/10Enrollment of US Bridge to Transplant Trial CompletedPrinter Friendly Version
02/09/10Fourth Quarter and Annual Results for 2009 Earnings CallPrinter Friendly Version
02/03/10Completion of US$62 million Capital RaisingPrinter Friendly Version
02/03/10Capital Raising - Cleansing NoticePrinter Friendly Version
02/03/10Capital Raising - ASX Appendix 3B AllotmentPrinter Friendly Version
02/01/10Exercise and Cancellation of OptionsPrinter Friendly Version
01/28/10Pricing of Public Offering of Common StockPrinter Friendly Version
01/27/10Prospectus for Public Offering of HeartWare Common StockPrinter Friendly Version
01/27/10Public Offering of HeartWare Common StockPrinter Friendly Version
01/12/10Shareholder UpdatePrinter Friendly Version
01/04/10Thoratec Loan Facility UpdatePrinter Friendly Version

 
 
Copyright © HeartWare International, Inc.